A Second Baby Died In A Gene Therapy Study — Slugging This Biotech StockInvestors Business Daily • 04/22/19
Novartis' BLA Acceptance Allows Entrance Into Large And Turbulent Wet AMD MarketSeeking Alpha • 04/17/19
Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New DealZacks Investment Research • 04/12/19
Novartis completed its spin-off of eye care specialist Alcon and Zogenix had a drug application rejected.The Motley Fool • 04/09/19
Novartis Lawsuit Accuses Amgen Of Trying To Welsh On Migraine DealInvestors Business Daily • 04/04/19
The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis EarningsBenzinga • 04/03/19
3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab FlopThe Motley Fool • 03/30/19
Pharma Stock Roundup: AZN Inks Cancer Deal, ABBV, NVS & Others Get Drug ApprovalsZacks Investment Research • 03/29/19
The Hits Just Keep Coming For Biogen As Rival Novartis Gains MS Drug ApprovalInvestors Business Daily • 03/27/19